Atkinson Arthur J
Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Transl Clin Pharmacol. 2018 Sep;26(3):111-114. doi: 10.12793/tcp.2018.26.3.111. Epub 2018 Sep 14.
Adding to the complexity of caring for critically ill patients is the fact that many of them have a creatinine clearance that exceeds 130 mL/min/1.73 m. This phenomenon, termed (ARC), has only recently been widely recognized and its pathogenesis remains incompletely understood. However, ARC has been shown to result in increased dose requirements for drugs that are primarily eliminated by renal excretion, including many antimicrobial agents and enoxaparin. Recognition of ARC is hampered by the fact that the standard creatinine-based equations used to estimate renal function are not accurate in this clinical setting and the diagnosis is best established using both serum and urine creatinine measurements to calculate clearance. So a high index of clinical suspicion and awareness is usually required before this step is taken to confirm the diagnosis of ARC.
重症患者护理工作的复杂性还体现在,许多患者的肌酐清除率超过130 mL/(min·1.73 m²)。这种现象被称为(ARC),直到最近才得到广泛认可,其发病机制仍未完全明确。然而,ARC已被证明会导致主要经肾脏排泄的药物(包括许多抗菌药物和依诺肝素)的剂量需求增加。由于用于估算肾功能的基于肌酐的标准公式在此临床环境中并不准确,且诊断最好通过血清和尿肌酐测量来计算清除率,这一事实阻碍了对ARC的识别。因此,在采取这一步骤确认ARC诊断之前,通常需要高度的临床怀疑和警惕。